Detalles de la búsqueda
1.
The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry.
Respir Res
; 25(1): 255, 2024 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38907239
2.
Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement.
J Med Virol
; 93(9): 5367-5375, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33913536
3.
The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study.
Cardiovasc Diabetol
; 14: 10, 2015 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25616979
4.
Observational study of kidney function and albuminuria in patients with type 2 diabetes treated with exenatide BID versus insulin glargine.
Ann Pharmacother
; 48(5): 571-6, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24497624
5.
Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey.
Infect Dis Ther
; 13(4): 685-697, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483775
6.
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals.
J Med Econ
; 27(1): 240-252, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294309
7.
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.
Cardiovasc Diabetol
; 12: 48, 2013 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23522121
8.
Mechanical ventilation for COVID-19: Outcomes following discharge from inpatient treatment.
PLoS One
; 18(1): e0277498, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36608047
9.
Development and validation of the self-management profile for type 2 diabetes (SMP-T2D).
Health Qual Life Outcomes
; 10: 125, 2012 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23039868
10.
Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis.
BMJ Open
; 11(6): e042246, 2021 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34135030
11.
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.
Arthritis Res Ther
; 23(1): 8, 2021 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407817
12.
Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis.
Rheumatol Ther
; 8(2): 693-710, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34037968
13.
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry.
Rheumatol Ther
; 8(1): 467-481, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33630272
14.
Preference values associated with stage III colon cancer and adjuvant chemotherapy.
Qual Life Res
; 19(3): 391-400, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20084462
15.
Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis.
Rheumatol Ther
; 7(1): 165-171, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31907758
16.
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic.
Rheumatol Ther
; 7(2): 345-355, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32227284
17.
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry.
Rheumatol Ther
; 7(2): 357-369, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232740
18.
Effectiveness of Tocilizumab in Patients with Rheumatoid Arthritis Is Unaffected by Comorbidity Burden or Obesity: Data from a US Registry.
J Rheumatol
; 47(10): 1464-1474, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31941801
19.
Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study.
Adv Ther
; 37(12): 4981-4995, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33044691
20.
Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database.
Rheumatol Ther
; 6(4): 599-610, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31656021